MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
VIVS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

VivoSim Lab (VIVS) Ownership - Who owns VivoSim Lab?

VivoSim Labs Inc formerly, Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data... Show more

Industry: #Biotechnology
#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Biotechnology
Address
N/A
Phone
N/A
Employees
N/A
Web
N/A

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
3.73M
P/E Ratio
0.73
Total Cash
4.29M
Projected Growth
N/A
Total Debt
577K
Revenue
142K
Risk (Beta)
1.60
Dividend Yield
N/A
Total Cash/Share
1.48
Total Debt/Equity
0.03
Revenue/Share
0.06 USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
VIVS
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for VIVS
A.I. Advisor
published General Information

General Information

a company which engages in developing and commercializing functional human tissues

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
N/A
Phone
N/A
Employees
N/A
Web
N/A